China Surpasses US in Drug Trials as Washington Responds - Pfizer (NYSE:PFE), Merck & Co (NYSE:MRK)

China tightens the reins on clinical trials, even as the U.S. looks for ways to replicate its rival’s speed

China has tightened regulations on investigator-initiated trials, with consequences not just for Chinese researchers but some Americans, too.